Skip to main content
GC CELL CORPORATION logo

GC CELL CORPORATION — Investor Relations & Filings

Ticker · 144510 ISIN · KR7144510005 KO Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2026-03-24 Declaration of Voting R…
Country KR South Korea
Listing KO 144510

About GC CELL CORPORATION

http://gccell.com/en/main.do

GC CELL CORPORATION specializes in cell and gene therapy, providing a fully integrated value chain from research to commercialization. The company's core offerings include end-to-end Contract Development and Manufacturing Organization (CDMO) services for autologous and allogeneic cell therapies, comprehensive bio-logistics, and cell banking. Its integrated model supports partners throughout the entire drug life cycle, from initial development and manufacturing to clinical trials and commercial distribution. In addition to its service-based solutions, GC CELL develops proprietary cell therapy products, including Immuncell-LC, an adjuvant therapy for hepatocellular carcinoma. The company focuses on advancing treatments in areas such as immune-oncology and delivering customized solutions to enhance patient outcomes.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is the formal announcement of the results of the company’s Annual General Meeting held on 2026-03-24, detailing the resolutions passed, vote percentages, and related matters. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-03-24 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Audit Report' (감사보고서) for GC Cell (주식회사 지씨셀) for the fiscal year ending December 31, 2025. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. While it contains financial data, it is a formal audit report rather than a full 10-K annual report (which would include management discussion and analysis, business overview, etc.) or a simple earnings release. Therefore, it is classified as an Audit Report. FY 2025
2026-03-16 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It contains detailed financial tables including consolidated and separate financial statements, audit opinions, and financial ratios for the fiscal year ending 2025-12-31. While it provides financial data, it is a structured regulatory disclosure of the audit results rather than the full Annual Report (10-K) or a simple announcement of report publication (RPA). Given the specific nature of audit report submissions in the Korean market, it falls under the category of Audit Report / Information. FY 2025
2026-03-16 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a correction (정정신고) to a previously filed 'Change in Sales or Profit/Loss Structure' report. It details specific financial adjustments made during the external audit process, including updated figures for net income and assets. Since this is a formal regulatory disclosure of financial performance changes rather than a full annual report or a simple announcement of a report's availability, it falls under the category of general regulatory filings.
2026-03-09 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for GC Cell. It contains the agenda for the upcoming Annual General Meeting (AGM), including financial statement approval, director appointments, and governance details. While it contains financial data, it is primarily a proxy solicitation document sent to shareholders to inform them of the meeting and request their votes (including electronic voting instructions). This fits the definition of a Proxy Solicitation & Information Statement.
2026-03-09 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains detailed information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures (electronic/written), and financial statements for the fiscal year. This document is a formal proxy solicitation material sent to shareholders to request their votes for the meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2026-03-09 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.